Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for prevention and treatment of post-dural puncture headache
IRCT20170516033992N4Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pregabalin in post-dural puncture headache (PDPH), sponsored by Urmia University of Medical Sciences. Started Dec 2019; status: completed.
02
Drugs
pregabalin
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on IRCT20170516033992N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170516033992N4.